News on Mesothelioma | Surviving Mesothelioma

Asia | Biomarkers | Diagnosis | International

SMRP Still Among Best Diagnostic Biomarkers for Mesothelioma
ByAlex Strauss April 5, 2019

Chinese researchers say soluble mesothelin-related peptides (SMRP) in lung fluid is still one of the best biomarkers for mesothelioma, even…

Read More SMRP Still Among Best Diagnostic Biomarkers for Mesothelioma
Australia | Chemotherapy | International | Mesothelioma | New Studies | Research | Treatments

Study Reveals Mesothelioma Chemotherapy May Be Underused in Older Patients
ByAlex Strauss April 2, 2019

The older a mesothelioma patient is, the less likely he or she may be to receive mesothelioma chemotherapy. A new…

Read More Study Reveals Mesothelioma Chemotherapy May Be Underused in Older Patients
Biopsy | Diagnosis | Europe | International | Radiation Therapy | Treatments

Prophylactic Radiation Will Not Prevent Pleural Mesothelioma Metastasis
ByAlex Strauss April 1, 2019

A UK study says prophylactic radiation of the chest wall is unlikely to prevent pleural mesothelioma metastasis. Pleural mesothelioma…

Read More Prophylactic Radiation Will Not Prevent Pleural Mesothelioma Metastasis
Chemotherapy | Multi-Modality Therapy | Treatments

Longer Mesothelioma Survival Possible with Long-Term Local Chemotherapy
ByAlex Strauss March 30, 2019April 1, 2019

There is evidence that repeatedly rinsing the abdomen with medicine might lead to longer mesothelioma survival after surgery. A rinse…

Read More Longer Mesothelioma Survival Possible with Long-Term Local Chemotherapy
Europe | Immune Systems | Immunotherapy | International | New Drugs | Research | Treatments

New Mesothelioma Clinical Trial Will Test Personalized Immunotherapy
ByAlex Strauss March 26, 2019April 23, 2019

A Dutch company has recruited the first patients into a pivotal mesothelioma clinical trial of autologous dendritic cells. Dendritic cells…

Read More New Mesothelioma Clinical Trial Will Test Personalized Immunotherapy
Chemotherapy | Europe | International | New Studies | Research | Treatments

Patients with Impaired Kidneys Could Still Take Alimta for Mesothelioma, Study Finds
ByAlex Strauss March 24, 2019

New research in the Netherlands suggests that patients who would not normally be prescribed Alimta for mesothelioma could still benefit…

Read More Patients with Impaired Kidneys Could Still Take Alimta for Mesothelioma, Study Finds
Australia | Holistic | International | Mesothelioma | New Studies | Prognosis | Research

Quality of Life for Mesothelioma Patients Hinges on Activity and Nutrition
ByAlex Strauss March 22, 2019

Muscle mass and nutrition can have a direct impact on quality of life for mesothelioma patients. That’s the finding of…

Read More Quality of Life for Mesothelioma Patients Hinges on Activity and Nutrition
Asia | Chemotherapy | International | Multi-Modality Therapy | New Studies | Research | Surgery | Treatments | Updates

Chemotherapy During Mesothelioma Surgery: Is it Dangerous?
ByAlex Strauss March 21, 2019

A new study finds that chemotherapy during mesothelioma surgery does not raise the risk for complications. That could be good…

Read More Chemotherapy During Mesothelioma Surgery: Is it Dangerous?
Asbestos | Europe | International | Occupations | Statistics

Risk of Dying from Mesothelioma Varies by Type, Study Shows
ByAlex Strauss March 18, 2019

The risk of dying from mesothelioma rises and gradually falls in the decades after exposure for most, but not all,…

Read More Risk of Dying from Mesothelioma Varies by Type, Study Shows
Asia | Chemotherapy | International | Surgery | Treatments

Conservative Surgery Leads to Better Mesothelioma Survival After Recurrence
ByAlex Strauss March 16, 2019

Mesothelioma survival after recurrence may be better with lung-preserving P/D surgery than with more radical EPP. Japanese researchers recently analyzed…

Read More Conservative Surgery Leads to Better Mesothelioma Survival After Recurrence

1 (888) 378-1331

SMRP Still Among Best Diagnostic Biomarkers for Mesothelioma

Study Reveals Mesothelioma Chemotherapy May Be Underused in Older Patients

Prophylactic Radiation Will Not Prevent Pleural Mesothelioma Metastasis

Longer Mesothelioma Survival Possible with Long-Term Local Chemotherapy

New Mesothelioma Clinical Trial Will Test Personalized Immunotherapy

Patients with Impaired Kidneys Could Still Take Alimta for Mesothelioma, Study Finds

Quality of Life for Mesothelioma Patients Hinges on Activity and Nutrition

Chemotherapy During Mesothelioma Surgery: Is it Dangerous?

Risk of Dying from Mesothelioma Varies by Type, Study Shows

Conservative Surgery Leads to Better Mesothelioma Survival After Recurrence

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES